BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 12, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 26, 2006
View Archived Issues
Pentavalent human-bovine vaccine reduces rotavirus gastroenteritis
Read More
Suberoylanilide hydroxamic acid active in lymphoma patients
Read More
Synbiotics maintain gut environment in severe SIRS patients
Read More
Update on biomarkers in breast cancer
Read More
Toyama outlicenses Korean rights for T-3811 to Dong-A
Read More
Promising preclinical results in Duchenne muscular dystrophy at VASTox
Read More
GemVax and Ulleval University Hospital collaborate on translational research
Read More
New subcutaneous formulation of Genasense investigated
Read More
Migenix profiles pipeline progress
Read More
Clinical candidate selected from Array BioPharma and AstraZeneca collaboration
Read More
Eurand inlicenses novel analgesic compounds from Italian universities
Read More
Can-Fite BioPharma signs CRADA with NIH for A3 adenosine receptor agonists
Read More
Posiphen completes first phase I study for Alzheimer's disease progression
Read More
New phase I study investigates PR-104 to treat hypoxic tumors
Read More
Curis updates phase I basal cell carcinoma study
Read More
Pfizer updates Canadian safety information for Macugen
Read More
New pegylated wortmannin conjugates demonstrate antitumor activity
Read More
LAB CGRP, safe with no serious adverse events in phase I study
Read More
Japanese approval for Plavix
Read More
Approvable letter for Yaz
Read More
GW-3965 protects against endotoxic liver injury and dysfunction
Read More
Novel agents for treating endocrine-related disorders disclosed in recent patents
Read More
Recent Vertex patent reports new agents for cystic fibrosis
Read More
Antiarrhythmic agents emerge from AstraZeneca R&D
Read More
Erectile dysfunction medications may be associated with increased risk of optic nerve damage
Read More
